SILICON Therapeutics Logo (EUIPO, 07/12/2021)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark SILICON Therapeutics was filed as Figurative mark on 07/12/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/21/2021.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Backgrounds, in words or numerals, divided into two, horizontally #One circle #One polygon #Polygons with one or more truncated or rounded angles #Polygons containing one or more circles or ellipses (specify the content) #Several ellipses, juxtaposed, tangential or intersecting #Blue #Black
| Trademark form | Figurative mark |
| File reference | 018511822 |
| Application date | July 12, 2021 |
| Publication date | September 13, 2021 |
| Entry date | December 21, 2021 |
| Expiration date | July 12, 2031 |
Trademark owner
151 W. 42ND Street,
10036 New York
US
10036 New York
US
Trademark representatives
Calle Italia, 22 Local Bajo
03003 Alicante
ES
goods and services
5
Pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes; Pharmaceutical preparations for human use for the treatment of central nervous system, neurological, dementia, dermatological, metabolic, hematologic, infectious, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions; Anti-cancer preparations; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Anti-cancer preparations of chemical origin; Anti-cancer preparations of plant origin; Anti-cancer preparations of microbial origin; Biopharmaceuticals for the treatment of cancer; Compounds for treating cancer; Biological preparations for medical purposes; Biological preparations for the treatment of cancer; Viral vaccines; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the prevention of inflammatory diseases; Pharmaceuticals; Chemico-pharmaceutical preparations; Antibacterial pharmaceuticals; Anti-microbial preparations; Chemical preparations for medical purposes; Chemical preparations for pharmaceutical purposes; Vaccines; Vaccine adjuvants; Pharmaceutical preparations comprising small molecules for degrading disease-causing cellular proteins for treatment in the field of oncology; pharmaceutical and biological preparations for treatment and prevention of cancer and for the treatment and prevention of auto-immune diseases and disorders and central nervous system and neurological diseases and disorders; Biological preparations for the treatment of viral infections; Biological preparations for the treatment of inflammatory conditions; Biological preparations for the treatment of age-related degenerative diseases; Biological preparations for the treatment of microbial, fungal and viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of age-related degenerative diseases and cancers; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment and prevention of viral infections; Pharmaceutical preparations for the treatment and prevention of microbial, fungal and viral infections; Pharmaceutical preparations for the treatment and prevention of inflammatory conditions; Pharmaceutical preparations for the treatment and prevention of age-related degenerative diseases; Vaccine preparations
42
Scientific and technological services and research and design relating thereto; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; biomedical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Pharmaceutical research and development; Product research and development; Scientific research and development; Pharmaceutical product development for new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology
44
Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 17, 2022 | Transfer / Change of address, Published | ||
| January 13, 2022 | Transfer / Change of address, Published |
ID: 11018511822